Minimal Hepatic Encephalopathy in Cirrhosis- How Long to Treat?
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2017/01/01
-
Journal
-
Indian UGC (journal)
-
Refrences44
-
Citations18
-
Omesh Goyal
-
Sandeep S. Sidhu
-
Harsh Kishore
Cite
Goyal, Omesh, et al. “Minimal Hepatic Encephalopathy in Cirrhosis- How Long to Treat?”. Annals of Hepatology, vol. 16, no. 1, 2017, pp. 115-22, https://doi.org/10.5604/16652681.1226822.
Goyal, O., Sidhu, S. S., & Kishore, H. (2017). Minimal Hepatic Encephalopathy in Cirrhosis- How Long to Treat?. Annals of Hepatology, 16(1), 115-122. https://doi.org/10.5604/16652681.1226822
Goyal O, Sidhu SS, Kishore H. Minimal Hepatic Encephalopathy in Cirrhosis- How Long to Treat?. Annals of Hepatology. 2017;16(1):115-22.
Journal Categories
Medicine
Internal medicine
Specialties of internal medicine
Medicine
Internal medicine
Specialties of internal medicine
Diseases of the digestive system
Gastroenterology
Medicine
Medicine (General)
You May Also Like
- The global burden of hepatitis C
- Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study
- Liver injury during highly pathogenic human coronavirus infections
- Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
- Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
Rifaximin vs. lactulose in treatment of minimal hepatic encephalopathy | Liver International |
| 43 | 2016 |
| Minimal Hepatic Encephalopathy and Critical Flicker Frequency Are Associated With Survival of Patients With Cirrhosis | Gastroenterology |
| 98 | 2015 |
Minimal Hepatic Encephalopathy: The Reality Beyond Our Eyes | Acta Médica Portuguesa |
| 3 | 2015 |
| Management of Covert Hepatic Encephalopathy | Journal of Clinical and Experimental Hepatology |
| 12 | 2015 |
| Minimal Hepatic Encephalopathy Impairs Quality of Life | Journal of Clinical and Experimental Hepatology |
| 52 | 2015 |
Refrences Analysis
The category
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the digestive system. Gastroenterology 24
is the most frequently represented among the references in this article. It primarily includes studies from Digestive Diseases and Sciences The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
Citations Analysis
The category
Medicine: Medicine (General) 11
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Norfloxacin is more effective than Rifaximin in avoiding bacterial translocation in an animal model of cirrhosis and was published in 2017. The most recent citation comes from a 2024 study titled Improved cognition after rifaximin treatment is associated with changes in intra- and inter-brain network functional connectivity. This article reached its peak citation in 2020, with 4 citations. It has been cited in 17 different journals, 29% of which are open access. Among related journals, the World Journal of Gastroenterology cited this research the most, with 2 citations. The chart below illustrates the annual citation trends for this article.